These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19746990)

  • 1. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.
    Gozal YM; Duong DM; Gearing M; Cheng D; Hanfelt JJ; Funderburk C; Peng J; Lah JJ; Levey AI
    J Proteome Res; 2009 Nov; 8(11):5069-79. PubMed ID: 19746990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
    Seyfried NT; Gozal YM; Donovan LE; Herskowitz JH; Dammer EB; Xia Q; Ku L; Chang J; Duong DM; Rees HD; Cooper DS; Glass JD; Gearing M; Tansey MG; Lah JJ; Feng Y; Levey AI; Peng J
    J Proteome Res; 2012 May; 11(5):2721-38. PubMed ID: 22416763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease.
    Woltjer RL; Cimino PJ; Boutté AM; Schantz AM; Montine KS; Larson EB; Bird T; Quinn JF; Zhang J; Montine TJ
    FASEB J; 2005 Nov; 19(13):1923-5. PubMed ID: 16129700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease.
    Donovan LE; Higginbotham L; Dammer EB; Gearing M; Rees HD; Xia Q; Duong DM; Seyfried NT; Lah JJ; Levey AI
    Proteomics Clin Appl; 2012 Apr; 6(3-4):201-11. PubMed ID: 22532456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration.
    Gozal YM; Seyfried NT; Gearing M; Glass JD; Heilman CJ; Wuu J; Duong DM; Cheng D; Xia Q; Rees HD; Fritz JJ; Cooper DS; Peng J; Levey AI; Lah JJ
    Mol Neurodegener; 2011 Nov; 6():82. PubMed ID: 22126117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration.
    Herskowitz JH; Seyfried NT; Duong DM; Xia Q; Rees HD; Gearing M; Peng J; Lah JJ; Levey AI
    J Proteome Res; 2010 Dec; 9(12):6368-79. PubMed ID: 20886841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.
    Diner I; Nguyen T; Seyfried NT
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology.
    Montero-Calle A; Coronel R; Garranzo-Asensio M; Solís-Fernández G; Rábano A; de Los Ríos V; Fernández-Aceñero MJ; Mendes ML; Martínez-Useros J; Megías D; Moreno-Casbas MT; Peláez-García A; Liste I; Barderas R
    Cell Mol Life Sci; 2023 May; 80(6):141. PubMed ID: 37149819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
    Bai B; Hales CM; Chen PC; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C; Cantero G; Cheng D; Jones DR; Wu Z; Li Y; Diner I; Heilman CJ; Rees HD; Wu H; Lin L; Szulwach KE; Gearing M; Mufson EJ; Bennett DA; Montine TJ; Seyfried NT; Wingo TS; Sun YE; Jin P; Hanfelt J; Willcock DM; Levey A; Lah JJ; Peng J
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16562-7. PubMed ID: 24023061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease.
    Yu K; Niu M; Wang H; Li Y; Wu Z; Zhang B; Haroutunian V; Peng J
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):936-945. PubMed ID: 33683887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated tau interactome in the human Alzheimer's disease brain.
    Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
    Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutation.
    Papegaey A; Eddarkaoui S; Deramecourt V; Fernandez-Gomez FJ; Pantano P; Obriot H; Machala C; Anquetil V; Camuzat A; Brice A; Maurage CA; Le Ber I; Duyckaerts C; Buée L; Sergeant N; Buée-Scherrer V
    Acta Neuropathol Commun; 2016 Jul; 4(1):74. PubMed ID: 27435172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain.
    Kepchia D; Huang L; Dargusch R; Rissman RA; Shokhirev MN; Fischer W; Schubert D
    Alzheimers Res Ther; 2020 Jun; 12(1):75. PubMed ID: 32560738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.
    Ayyadevara S; Balasubramaniam M; Parcon PA; Barger SW; Griffin WS; Alla R; Tackett AJ; Mackintosh SG; Petricoin E; Zhou W; Shmookler Reis RJ
    Aging Cell; 2016 Oct; 15(5):924-39. PubMed ID: 27448508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
    Heywood WE; Galimberti D; Bliss E; Sirka E; Paterson RW; Magdalinou NK; Carecchio M; Reid E; Heslegrave A; Fenoglio C; Scarpini E; Schott JM; Fox NC; Hardy J; Bhatia K; Heales S; Sebire NJ; Zetterberg H; Mills K
    Mol Neurodegener; 2015 Dec; 10():64. PubMed ID: 26627638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.